Don’t miss the latest developments in business and finance.

Home / Content / B2B Connect / Pharma / Lupin receives US FDA approval for generic Suprep bowel prep kit

Lupin receives US FDA approval for generic Suprep bowel prep kit

The company has also received US drug regulator's nod for generic Percocet tablet, a pain killer

Lupin receives US FDA for electrolyte replenisher
Premium
BS B2B Bureau Mumbai
Last Updated : Feb 28 2017 | 1:35 PM IST
Connect with us
Facebook IconLinkedIN Icon
Lupin Ltd has received final approval for its sodium sulfate, potassium sulfate, and magnesium sulfate oral solution, 17.5 g/3.13 g/1.6 g per 6 ounces, from the US Food and Drug Administration (FDA) to market a generic version of Braintree Laboratories’ Suprep bowel prep kit. 

According to Lupin, it is eligible for 180 days of generic drug exclusivity for the approved product, which indicated for cleansing of the colon in preparation for colonoscopy in adults. As per IMS (MAT December 2016), Suprep bowel prep kit had US sales of $ 207.2 million.

Meanwhile, Lupin Limited has also received final approval for its oxycodone & acetaminophen tablet (2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg) from the US drug regulator. The approved product is a generic version of Vintage Pharmaceuticals’ Percocet tablet, which is indicated for relief of moderate to moderately severe pain. According to IMS Health, Percocet tablet recorded annual US sales of $ 838.7 million in 2016.
Connect with us on WhatsApp

More From This Section

Lupin arm Kyowa inks pact with Astellas Pharma to sell antidepressant drug

Zydus Cadila to launch tetravalent influenza vaccine in India

Arrival of foreign tourists on medical visa witnessing phenomenal growth

Zydus Cadila receives US FDA nod for anti-fungal drug fluconazole tablet

First Published: Feb 28 2017 | 1:32 PM IST

Explore News

Next Story